| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S0031182015001341 |
| P698 | PubMed publication ID | 26743529 |
| P50 | author | Teun Bousema | Q44168464 |
| Chris J Drakeley | Q56774786 | ||
| Kathleen W Dantzler | Q56804652 | ||
| Matthias Marti | Q70202987 | ||
| Will Stone | Q84532639 | ||
| P2093 | author name string | Sandra K Nilsson | |
| Sanna R Rijpma | |||
| P2860 | cites work | Revisiting the basic reproductive number for malaria and its implications for malaria control | Q21090219 |
| Artemisinin Resistance in Plasmodium falciparum Malaria | Q22061852 | ||
| Acquired immunity to malaria | Q24651173 | ||
| A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria | Q27861951 | ||
| Proteins of the malaria parasite sexual stages: expression, function and potential for transmission blocking strategies | Q27973462 | ||
| Identification and stoichiometry of glycosylphosphatidylinositol-anchored membrane proteins of the human malaria parasite Plasmodium falciparum | Q27973463 | ||
| PSLAP, a protein with multiple adhesive motifs, is expressed in Plasmodium falciparum gametocytes | Q28216287 | ||
| Identification of xanthurenic acid as the putative inducer of malaria development in the mosquito | Q28265888 | ||
| A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses | Q28301446 | ||
| Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies | Q28475084 | ||
| Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriers | Q28482471 | ||
| Inferring developmental stage composition from gene expression in human malaria | Q28536897 | ||
| The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania | Q28744581 | ||
| A proteomic view of the Plasmodium falciparum life cycle | Q29618807 | ||
| Universal features of post-transcriptional gene regulation are critical for Plasmodium zygote development | Q30038970 | ||
| Protein export marks the early phase of gametocytogenesis of the human malaria parasite Plasmodium falciparum | Q30042317 | ||
| Cellular location and temporal expression of the Plasmodium falciparum sexual stage antigen Pfs16 | Q30043034 | ||
| A central role for P48/45 in malaria parasite male gamete fertility | Q30043154 | ||
| Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data. | Q30982324 | ||
| Plasmodium falciparum antigens on the surface of the gametocyte-infected erythrocyte | Q33338492 | ||
| Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51. | Q33350210 | ||
| Rapid assessment of malaria transmission using age-specific sero-conversion rates | Q33475618 | ||
| A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli | Q33485233 | ||
| Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission | Q33520254 | ||
| Molecular evidence for the localization of Plasmodium falciparum immature gametocytes in bone marrow | Q33794320 | ||
| A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray | Q33859633 | ||
| Phagocytosis does not play a major role in naturally acquired transmission-blocking immunity to Plasmodium falciparum malaria | Q33867110 | ||
| Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward | Q44144794 | ||
| Plasmodium cynomolgi: serum-mediated blocking and enhancement of infectivity to mosquitoes during infections in the natural host, Macaca sinica | Q44145797 | ||
| Asymptomatic malaria infections: detectability, transmissibility and public health relevance | Q44146283 | ||
| Antibodies to plasmodium falciparum gamete surface antigens in papua new guinea sera | Q44150700 | ||
| Transmission blockade of Plasmodium falciparum: its variability with gametocyte numbers and concentration of antibody | Q44150859 | ||
| Stage-specific effects of host plasma factors on the early sporogony of autologous Plasmodium falciparum isolates within Anopheles gambiae | Q44161813 | ||
| Proteome analysis of separated male and female gametocytes reveals novel sex-specific Plasmodium biology | Q44164874 | ||
| Malaria transmission-blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production | Q44169388 | ||
| Plasmodium falciparum malaria transmission-blocking immunity under conditions of low endemicity as in Sri Lanka | Q44170313 | ||
| Malaria transmission-blocking activity in experimental infections of Anopheles gambiae from naturally infected Plasmodium falciparum gametocyte carriers | Q44171426 | ||
| The effect of transmission-blocking antibody ingested in primary and secondary bloodfeeds, upon the development of Plasmodium berghei in the mosquito vector | Q44171631 | ||
| Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. | Q44171862 | ||
| (Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate | Q46962726 | ||
| Severity of anaemia is associated with bone marrow haemozoin in children exposed to Plasmodium falciparum | Q47850084 | ||
| Commitment to sexual differentiation in the human malaria parasite, Plasmodium falciparum | Q47874193 | ||
| Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry | Q47915916 | ||
| Quantification of Plasmodium falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification | Q47990457 | ||
| Transmission blocking immunity as observed in a feeder system and serological reactivity to Pfs 48/45 and Pfs230 in field sera | Q48000078 | ||
| Plasmodium falciparum: An abundant stage-specific protein expressed during early gametocyte development | Q57044263 | ||
| Genome-wide identification of genes upregulated at the onset of gametocytogenesis in Plasmodium falciparum | Q57443323 | ||
| Characterization of the effector mechanisms of a transmission-blocking antibody upon differentiation of Plasmodium berghei gametocytes into ookinetes in vitro | Q72124570 | ||
| A study of gametocytes in a West African strain of Plasmodium falciparum | Q75685108 | ||
| Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs | Q33898575 | ||
| Effect of ingested human antibodies induced by RTS, S/AS01 malaria vaccination in children on Plasmodium falciparum oocyst formation and sporogony in mosquitoes | Q33909124 | ||
| A cascade of DNA-binding proteins for sexual commitment and development in Plasmodium | Q33929633 | ||
| Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial | Q34043843 | ||
| Differential adhesive properties of sequestered asexual and sexual stages of Plasmodium falciparum on human endothelial cells are tissue independent | Q34171103 | ||
| Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination | Q34177472 | ||
| Plasmodium falciparum transmission stages accumulate in the human bone marrow | Q34245311 | ||
| Sex-partitioning of the Plasmodium falciparum stage V gametocyte proteome provides insight into falciparum-specific cell biology | Q34303401 | ||
| The plasticity of Plasmodium falciparum gametocytaemia in relation to age in Burkina Faso | Q34488590 | ||
| Profiling humoral immune responses to P. falciparum infection with protein microarrays | Q34495128 | ||
| CD36-mediated nonopsonic phagocytosis of erythrocytes infected with stage I and IIA gametocytes of Plasmodium falciparum | Q34521530 | ||
| Human immune responses that reduce the transmission of Plasmodium falciparum in African populations | Q34641186 | ||
| Regulation of sexual development of Plasmodium by translational repression | Q35090746 | ||
| Transcriptional profiling defines dynamics of parasite tissue sequestration during malaria infection | Q35125730 | ||
| Virulence and transmission success of the malarial parasite Plasmodium falciparum | Q35132510 | ||
| A plant-produced Pfs230 vaccine candidate blocks transmission of Plasmodium falciparum | Q35138735 | ||
| Infectiousness of the human population to Anopheles arabiensis by direct skin feeding in an area hypoendemic for malaria in Senegal | Q35150377 | ||
| A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines | Q35544571 | ||
| Disruption of Plasmodium falciparum development by antibodies against a conserved mosquito midgut antigen | Q35941338 | ||
| Host cell deformability is linked to transmission in the human malaria parasite Plasmodium falciparum. | Q36035540 | ||
| Proteomic analysis of Plasmodium in the mosquito: progress and pitfalls. | Q36159362 | ||
| Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential | Q36229989 | ||
| Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum | Q36348052 | ||
| Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito | Q36351262 | ||
| Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice | Q36670217 | ||
| Population dynamics of Plasmodium sporogony | Q36692285 | ||
| Plasmodium knowlesi: persistence of transmission blocking immunity in monkeys immunized with gamete antigens. | Q37081375 | ||
| Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay | Q37336089 | ||
| Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets? | Q37487002 | ||
| Plasmodium berghei HAP2 induces strong malaria transmission-blocking immunity in vivo and in vitro | Q37549510 | ||
| Distinct trafficking and localization of STEVOR proteins in three stages of the Plasmodium falciparum life cycle | Q37582797 | ||
| Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle | Q37600561 | ||
| Toward the development of effective transmission-blocking vaccines for malaria | Q38322553 | ||
| Assessing the infectious reservoir of falciparum malaria: past and future | Q38488692 | ||
| Development of malaria transmission-blocking vaccines: from concept to product | Q38499527 | ||
| The Plasmodium falciparum sexual development transcriptome: a microarray analysis using ontology-based pattern identification | Q38520062 | ||
| A flow cytometry-based workflow for detection and quantification of anti-plasmodial antibodies in vaccinated and naturally exposed individuals | Q38864802 | ||
| Can field-based mosquito feeding assays be used for evaluating transmission-blocking interventions? | Q38917760 | ||
| Parasite infectivity and immunity to Plasmodium falciparum gametocytes in Gambian children | Q38977779 | ||
| Transmission-blocking effects of sera from malaria-exposed individuals on Plasmodium falciparum isolates from gametocyte carriers | Q38977787 | ||
| Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidates | Q39018502 | ||
| The primary antibody response of malaria patients to Plasmodium falciparum sexual stage antigens which are potential transmission blocking vaccine candidates | Q39324954 | ||
| A model for sequestration of the transmission stages of Plasmodium falciparum: adhesion of gametocyte-infected erythrocytes to human bone marrow cells. | Q39405774 | ||
| Programmed transcription of the var gene family, but not of stevor, in Plasmodium falciparum gametocytes | Q39453367 | ||
| A scalable assessment of Plasmodium falciparum transmission in the standard membrane-feeding assay, using transgenic parasites expressing green fluorescent protein-luciferase | Q39492523 | ||
| The cell biology of sexual development in Plasmodium | Q40107209 | ||
| Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients | Q40733654 | ||
| Measurement by membrane feeding of reduction in Plasmodium falciparum transmission induced by endemic sera | Q40959724 | ||
| Transmission blocking malaria vaccines: Assays and candidates in clinical development | Q40979878 | ||
| Plasmodium gallinaceum: transmission-blocking immunity in chickens. I. Comparative immunogenicity of gametocyte- and gamete-containing preparations | Q41555672 | ||
| Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages | Q41835030 | ||
| Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes | Q41946006 | ||
| Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence | Q42127740 | ||
| The extravascular compartment of the bone marrow: a niche for Plasmodium falciparum gametocyte maturation? | Q42424857 | ||
| Successful immunization against the sexual stages of Plasmodium gallinaceum | Q42979860 | ||
| Malaria transmission blocked by immunisation with gametes of the malaria parasite | Q42979953 | ||
| Measuring the blockade of malaria transmission--an analysis of the Standard Membrane Feeding Assay | Q43571629 | ||
| Submicroscopic Plasmodium falciparum gametocyte carriage is common in an area of low and seasonal transmission in Tanzania | Q43736591 | ||
| Malaria transmission-blocking vaccines | Q43796267 | ||
| A longitudinal study of immune responses to Plasmodium falciparum sexual stage antigens in Tanzanian adults | Q43945792 | ||
| Reduction and enhancement of Plasmodium falciparum transmission by endemic human sera | Q43946800 | ||
| Transmission-reducing immunity is inversely related to age in Plasmodium falciparum gametocyte carriers | Q43946977 | ||
| Association between anti-Pfs48/45 reactivity and P. falciparum transmission-blocking activity in sera from Cameroon | Q44137386 | ||
| The roles of temperature, pH and mosquito factors as triggers of male and female gametogenesis of Plasmodium berghei in vitro | Q44137607 | ||
| Enhanced gametocyte formation in erythrocyte progenitor cells: a site-specific adaptation by Plasmodium falciparum. | Q44137813 | ||
| Mechanisms that reduce transmission of Plasmodium falciparum malaria in semiimmune and nonimmune persons | Q44138775 | ||
| Gametocytes of Plasmodium falciparum: phagocytosis by leucocytes in vivo and in vitro | Q44139740 | ||
| Plasmodium falciparum: membrane feeding assays and competition ELISAs for the measurement of transmission reduction in sera from Cameroon | Q44140956 | ||
| Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230. | Q44142097 | ||
| Transmission blocking immunity to human Plasmodium vivax malaria in an endemic population in Kataragama, Sri Lanka | Q44142213 | ||
| Properties of epitopes of pfs 48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of plasmodium falciparum | Q44143594 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 187-198 | |
| P577 | publication date | 2016-01-08 | |
| P1433 | published in | Parasitology | Q15753259 |
| P1476 | title | Naturally acquired immunity to sexual stage P. falciparum parasites | |
| P478 | volume | 143 |
| Q50318730 | A randomized feasibility trial comparing four antimalarial drug regimens to induce Plasmodium falciparum gametocytemia in the controlled human malaria infection model |
| Q40118467 | An N-terminal Pfs230 domain produced in baculovirus as a biological active transmission-blocking vaccine candidate |
| Q42682357 | Comparative assessment of An. gambiae and An. stephensi mosquitoes to determine transmission-reducing activity of antibodies against P. falciparum sexual stage antigens |
| Q37400894 | Comparison of molecular quantification of Plasmodium falciparum gametocytes by Pfs25 qRT-PCR and QT-NASBA in relation to mosquito infectivity |
| Q40105545 | Concentration of Plasmodium falciparum gametocytes in whole blood samples by magnetic cell sorting enhances parasite infection rates in mosquito feeding assays |
| Q59791183 | Cryogenically preserved RBCs support gametocytogenesis of Plasmodium falciparum in vitro and gametogenesis in mosquitoes |
| Q93099494 | Display of malaria transmission-blocking antigens on chimeric duck hepatitis B virus-derived virus-like particles produced in Hansenula polymorpha |
| Q28365035 | Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate |
| Q62960064 | Identification of domains within Pfs230 that elicit transmission blocking antibody responses |
| Q63493282 | Immune Responses to the Sexual Stages of Parasites |
| Q92001627 | Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites |
| Q61448744 | Low Levels of Human Antibodies to Gametocyte-Infected Erythrocytes Contrasts the PfEMP1-Dominant Response to Asexual Stages in Malaria |
| Q90024117 | Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity |
| Q54217209 | Modeling the impact of Plasmodium falciparum sexual stage immunity on the composition and dynamics of the human infectious reservoir for malaria in natural settings. |
| Q64898220 | Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum. |
| Q54255226 | Plasmodium Gametocytes in Field Studies: Do We Measure Commitment to Transmission or Detectability? |
| Q37491136 | Plasmodium falciparum genotype and gametocyte prevalence in children with uncomplicated malaria in coastal Ghana |
| Q39343656 | Prevalence of Plasmodium falciparum transmission reducing immunity among primary school children in a malaria moderate transmission region in Zimbabwe |
| Q38818196 | Recognition of Plasmodium falciparum mature gametocyte-infected erythrocytes by antibodies of semi-immune adults and malaria-exposed children from Gabon |
| Q57154118 | Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody |
| Q58115505 | Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45 |
| Q38840716 | The Relative Effects of Artemether-lumefantrine and Non-artemisinin Antimalarials on Gametocyte Carriage and Transmission of Plasmodium falciparum: A Systematic Review and Meta-analysis |
| Q38789240 | The s48/45 six-cysteine proteins: mediators of interaction throughout the Plasmodium life cycle |
| Q38775588 | Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine |
| Q49732059 | Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity |
Search more.